{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:39:03Z","timestamp":1791250743492,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2008,7,2]],"date-time":"2008-07-02T00:00:00Z","timestamp":1214956800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0002573","type":"journal-article","created":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T22:27:19Z","timestamp":1214951239000},"page":"e2573","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":64,"title":["An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load"],"prefix":"10.1371","volume":"3","author":[{"given":"Yen","family":"Ngo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ingiliz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Munteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Lebray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Thabut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Morra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamila","family":"Messous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Charlotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Imbert-Bismut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Rousselot-Bonnefont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Moussalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Ratziu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Poynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,7,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B.","volume":"45","author":"AS Lok","year":"2007","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/0003-4819-147-1-200707030-00010","article-title":"The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points.","volume":"147","author":"CL Lai","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors.","volume":"48","author":"G Fattovich","year":"2008","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jhep.2007.07.022","article-title":"The clinical significance of persistently normal ALT in chronic hepatitis B infection.","volume":"47","author":"M Lai","year":"2007","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1440-1746.2007.04857.x","article-title":"Long-term outcome of chronic hepatitis B based on histological grade and stage.","volume":"22","author":"BK Park","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/hep.1840210308","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients.","volume":"21","author":"S Takano","year":"1995","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0168-8278(98)80339-5","article-title":"Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation in 2215 patients.","volume":"28","author":"K Ikeda","year":"1998","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.3748\/wjg.v12.i23.3682","article-title":"Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.","volume":"12","author":"G Sebastiani","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1053\/j.gastro.2005.02.056","article-title":"Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy?","volume":"128","author":"T Poynard","year":"2005","journal-title":"Gastroenterology"},{"key":"ref10","first-page":"40","article-title":"Meta-analyses of Fibrotest diagnostic value in chronic liver disease BMC Gastroenterology,","volume":"7","author":"T Poynard","year":"2007"},{"key":"ref11","first-page":"129","article-title":"Relationship between serum HBV DNA levels and hepatic fibrosis markers in chronic hepatitis B.","volume":"21","author":"Z Dong","year":"2007","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"ref12","first-page":"483","article-title":"Viral load speaks little about toll on liver.","volume":"6","author":"MA Mahtab","year":"2007","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(03)00171-5","article-title":"Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.","volume":"39","author":"RP Myers","year":"2003","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1111\/j.1572-0241.2005.41957.x","article-title":"Longitudinal assessment of histology surrogate markers (Fibrotest-Actitest) during lamivudine therapy in patients with chronic hepatitis B infection.","volume":"100","author":"T Poynard","year":"2005","journal-title":"Am J Gast"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3748\/wjg.v13.i4.525","article-title":"Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B.","volume":"13","author":"G Sebastiani","year":"2007","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S298","DOI":"10.1016\/S0168-8278(07)62390-3","article-title":"Adefovir Dipivoxil 437 and 438 Study Groups. Impact of adefovir dipivoxil on liver fibrosis and activity assessed with FibroTest-ActiTest in patients with chronic hepatitis B infection.","volume":"46","author":"T Poynard","year":"2007","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1373\/clinchem.2007.085795","article-title":"Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalence's of fibrosis Stages.","volume":"53","author":"T Poynard","year":"2007","journal-title":"Clin Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/096228029800700404","article-title":"Evaluation of diagnostic tests without gold standards.","volume":"7","author":"SL Hui","year":"1998","journal-title":"Statistical Methods in Medical Research"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C.","volume":"38","author":"P Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1373\/clinchem.2004.032227","article-title":"Prospective analysis of discordant results between biochemical markers and biopsy in patients with Chronic Hepatitis C.","volume":"50","author":"T Poynard","year":"2004","journal-title":"Clin Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1373\/clinchem.2006.070961","article-title":"A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.","volume":"52","author":"Y Ngo","year":"2006","journal-title":"Clin Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1515\/cclm.2004.42.6.681","article-title":"Intralaboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.","volume":"42","author":"F Imbert-Bismut","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.510270505","article-title":"Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.","volume":"27","author":"A Piton","year":"1998","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1515\/CCLM.2006.078","article-title":"Intermethod calibration of alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) results: application to Fibrotest and Actitest scores.","volume":"44","author":"G F\u00e9rard","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group.","volume":"24","author":"P Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophagus varices.","volume":"60","author":"R Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.","volume":"38","author":"CT Wai","year":"2003","journal-title":"Hepatology"},{"key":"ref28","article-title":"NCSS 2003 User Guide. Number Cruncher Statistical Systems","author":"JL Hintze","year":"2003"},{"key":"ref29","article-title":"Tables de mortalit\u00e9 fran\u00e7aises pour les XIXe et Xxe si\u00e8cles et projections pour le XXIe si\u00e8cle.","author":"J Vallin","year":"2001","journal-title":"Institut National d'Etudes D\u00e9mographiques"},{"key":"ref30","article-title":"Instructions to IBM 650 Programmers in Processing Survival Computations. Methodological Note No. 10, End Results Evaluation Section","author":"F Ederer","year":"1959"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.","volume":"44","author":"ER DeLong","year":"1988","journal-title":"Biometrics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0272989X8900900307","article-title":"Analyzing a portion of the ROC curve.","volume":"9","author":"DK McClish","year":"1989","journal-title":"Med Decis Making"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1002\/9780470317082","article-title":"Statistical Methods in Diagnostic Medicine","author":"X Zhou","year":"2002"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cgh.2007.06.015","article-title":"Risk Evaluation of Viral Load Elevation and Associated Liver Disease\/Cancer-Hepatitis B Virus Study Group. Risk and predictors of mortality associated with chronic hepatitis B infection.","volume":"5","author":"UH Iloeje","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref35","first-page":"19","article-title":"Long term follow-up of a large cohort of inactive HbsAg (+)\/ HbeAg (\u2212)\/ anti-Hbe (+) carriers in Greece.","volume":"16","author":"E Gigi","year":"2007","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cgh.2007.01.005","article-title":"Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.","volume":"5","author":"T Andreani","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jhep.2008.01.025","article-title":"Comparison of non-invasive liver fibrosis biomarkers in HIV\/HCV co-infected patients: The fibrovic study \u2013 ANRS HC02.","volume":"48","author":"P Cacoub","year":"2008","journal-title":"J Hepatol"},{"key":"ref38","first-page":"1","article-title":"A regulatory authority's opinion about surrogate endpoints.","author":"RJ Temple","year":"1995","journal-title":"Clinical measurement in drug evaluation"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejca.2004.12.006","article-title":"New science-based endpoints to accelerate oncology drug development.","volume":"41","author":"GJ Kelloff","year":"2005","journal-title":"Eur J Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2893.2002.00341.x","article-title":"Biochemical markers of liver fibrosis in patients infected by Hepatitis C Virus: Longitudinal validation in a randomized trial.","volume":"9","author":"T Poynard","year":"2002","journal-title":"J Viral Hepatitis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/jhep.2003.50319","article-title":"Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.","volume":"38","author":"T Poynard","year":"2003","journal-title":"Hepatology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1515\/CCLM.2005.095","article-title":"A reference material for traceability of aspartate aminotransferase (AST) results.","volume":"43","author":"G F\u00e9rard","year":"2005","journal-title":"Clin Chem Lab Med"}],"updated-by":[{"DOI":"10.1371\/annotation\/9f8332b9-fdc0-48e8-967b-3c504024b9d1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2008,7,11]],"date-time":"2008-07-11T00:00:00Z","timestamp":1215734400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0002573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:53:02Z","timestamp":1540216382000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0002573"}},"subtitle":[],"editor":[{"given":"Niyaz","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,7,2]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2008,7,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0002573","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/9f8332b9-fdc0-48e8-967b-3c504024b9d1","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,2]]}}}